Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.9802
+0.0290 (3.05%)
At close: Dec 26, 2025, 4:00 PM EST
0.9900
+0.0098 (1.00%)
After-hours: Dec 26, 2025, 4:36 PM EST
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $6.19 million as of December 26, 2025. Its market cap has decreased by -67.36% in one year.
Market Cap
6.19M
Enterprise Value
-7.53M
1-Year Change
-67.36%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $6.19M, a decrease of -67.33%. That is a compound annual growth rate of -26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 6.19M | -65.41% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |